These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 3613754)

  • 1. Efficacy of two leukotriene antagonists in rat traumatic shock.
    Levitt MA; Lefer AM
    Methods Find Exp Clin Pharmacol; 1987 May; 9(5):269-73. PubMed ID: 3613754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Protective effects of a new LTD4 antagonist (LY-171883) in traumatic shock.
    Hock CE; Lefer AM
    Circ Shock; 1985; 17(4):263-72. PubMed ID: 3841503
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-shock properties of the prostacyclin analog, iloprost, in traumatic shock.
    Levitt MA; Lefer AM
    Prostaglandins Leukot Med; 1986 Dec; 25(2-3):175-85. PubMed ID: 2434958
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Beneficial actions of BN 50739, a new PAF receptor antagonist, in murine traumatic shock.
    Karasawa A; Rochester JA; Lefer AM
    Methods Find Exp Clin Pharmacol; 1990 May; 12(4):231-7. PubMed ID: 2165204
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of the novel cardiotonic and vasodilator agent pimobendan in traumatic shock.
    Bitterman H; Smith BA; Lefer AM
    Arzneimittelforschung; 1988 Oct; 38(10):1389-93. PubMed ID: 3196378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protective effects of a combination thromboxane synthesis inhibitor-receptor antagonist, R-68070, during murine traumatic shock.
    Aoki N; Johnson G; Siegfried MR; Lefer AM
    Eicosanoids; 1989; 2(3):169-74. PubMed ID: 2534278
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Beneficial effect of a thromboxane synthetase inhibitor in traumatic shock.
    Hock CE; Lefer AM
    Circ Shock; 1984; 14(3):159-68. PubMed ID: 6542462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of a combination thromboxane receptor antagonist and lipoxygenase inhibitor in traumatic shock.
    Levitt MA; Stahl G; Lefer AM
    Resuscitation; 1988 Jul; 16(3):211-20. PubMed ID: 2845544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beneficial actions of antagonism of peptide leukotrienes in hemorrhagic shock.
    Bitterman H; Smith BA; Lefer AM
    Circ Shock; 1988 Mar; 24(3):159-68. PubMed ID: 3383353
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Beneficial effects of prostaglandin E1 infusion in experimental traumatic shock.
    Levitt MA; Lefer AM
    Crit Care Med; 1987 Aug; 15(8):769-73. PubMed ID: 3608533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of adenosine, an adenosine-A1 antagonist, and their combination in splanchnic occlusion shock in rats.
    Karasawa A; Rochester JA; Lefer AM
    Circ Shock; 1992 Feb; 36(2):154-61. PubMed ID: 1582007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Anti-shock actions of the pyrimido-pyrimidine derivative, RA-642.
    Hock CE; Lefer DJ; Lefer AM
    Methods Find Exp Clin Pharmacol; 1986 May; 8(5):265-9. PubMed ID: 3724301
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protective actions of aprotinin in acute traumatic shock.
    Araki H; Lefer AM
    Arch Int Pharmacodyn Ther; 1979 Oct; 241(2):316-23. PubMed ID: 316692
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Salutary effects of anisodamine in murine traumatic shock.
    Hock CE; Su JY; Lefer AM
    Circ Shock; 1983; 11(3):211-6. PubMed ID: 6652878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protective effects of KW-3635, a novel thromboxane A2 antagonist, in murine traumatic shock.
    Karasawa A; Taylor PA; Lefer AM
    Eur J Pharmacol; 1990 Jun; 182(1):1-8. PubMed ID: 2401310
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protective effects of a specific platelet activating factor (PAF) antagonist, WEB 2086, in traumatic shock.
    Stahl GL; Bitterman H; Lefer AM
    Thromb Res; 1989 Feb; 53(3):327-38. PubMed ID: 2718150
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Protective actions of nafazatrom in traumatic shock.
    Lefer AM; Messenger M
    Arzneimittelforschung; 1982; 32(9):1089-91. PubMed ID: 6890831
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protective effects of a novel nonglucocorticoid 21-aminosteroid (U74006F) during traumatic shock in rats.
    Aoki N; Lefer AM
    J Cardiovasc Pharmacol; 1990 Feb; 15(2):205-10. PubMed ID: 1689414
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of CG-4203, a novel stable prostacyclin analog, in traumatic shock.
    Bitterman H; Stahl GL; Lefer AM
    Prostaglandins; 1988 Jan; 35(1):41-50. PubMed ID: 3287456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the protective effect of conditioning in rats subjected to Noble-Collip drum trauma.
    Galvin MJ; Sollott SJ; Lefer AM
    Circ Shock; 1979; 6(1):23-9. PubMed ID: 455590
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.